| Company Name: |
Bide Pharmatech Ltd.
|
| Tel: |
400-1647117 13681763483 |
| Email: |
product02@bidepharm.com |
| Products Intro: |
Product Name:(R)-N-(2-(5-Fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine
CAS:2247950-42-9
Purity:99% Package:10mg;25mg;50mg;100mg Remarks:BD01457139
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 15002144251 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:AHR antagonist 5 free base
CAS:2247950-42-9
Purity:99.88% Package:1removed
|
|
| | 1H-Carbazol-3-amine, N-[2-(5-fluoro-3-pyridinyl)-8-(1-methylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]-2,3,4,9-tetrahydro-, (3R)- Basic information |
| Product Name: | 1H-Carbazol-3-amine, N-[2-(5-fluoro-3-pyridinyl)-8-(1-methylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]-2,3,4,9-tetrahydro-, (3R)- | | Synonyms: | 1H-Carbazol-3-amine, N-[2-(5-fluoro-3-pyridinyl)-8-(1-methylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]-2,3,4,9-tetrahydro-, (3R)-;AHR antagonist 5 free base;AHR antagonist 5 free base, 10 mM in DMSO;IK-175 | | CAS: | 2247950-42-9 | | MF: | C25H24FN7 | | MW: | 441.5 | | EINECS: | | | Product Categories: | | | Mol File: | 2247950-42-9.mol | ![1H-Carbazol-3-amine, N-[2-(5-fluoro-3-pyridinyl)-8-(1-methylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]-2,3,4,9-tetrahydro-, (3R)- Structure](CAS/20210305/GIF/2247950-42-9.gif) |
| | 1H-Carbazol-3-amine, N-[2-(5-fluoro-3-pyridinyl)-8-(1-methylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]-2,3,4,9-tetrahydro-, (3R)- Chemical Properties |
| density | 1.45±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | form | Solid | | pka | 17.41±0.40(Predicted) | | color | White to off-white |
| | 1H-Carbazol-3-amine, N-[2-(5-fluoro-3-pyridinyl)-8-(1-methylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]-2,3,4,9-tetrahydro-, (3R)- Usage And Synthesis |
| Uses | IK-175 is a selective and orally active aryl hydrocarbon receptor (AHR) inhibitor. IK-175 effectively blocks AHR from translocating from the cytoplasm to the nucleus. IK-175 is highly selective for AHR over other receptors, transporters, and kinases[1]. | | Biological Activity | AHR antagonist 5 free base is a selective and orally active aryl hydrocarbon receptor (AHR) inhibitor. AHR antagonist 5 free base effectively blocks AHR from translocating from the cytoplasm to the nucleus. AHR antagonist 5 free base is highly selective for AHR over other receptors, transporters, and kinases[1].
AHR antagonist 5 free base (Compound A) potently inhibits AHR activity in human and rodent cell lines (IC50 of ~35-150 nM). In human T cell assays, AHR antagonist 5 free base induces an activated T cell state. AHR antagonist 5 free base inhibits CYP1A1 and interleukin (IL)-22 gene expression and leads to an increase in pro-inflammatory cytokines, such as IL-2 and IL-9[1].
AHR antagonist 5 free base (Compound A) has been evaluated in a series of pharmacological, single-dose and repeated-dose toxicological studies in rodent and non-rodent species including 28-day Good Laboratory Practice (GLP) studies in rat and monkeys. All changes are resolved or resolving after 2 weeks of dosing cessation, except for the testicular changes in rats[1]. | | in vivo | IK-175 (Compound A) has been evaluated in a series of pharmacological, single-dose and repeated-dose toxicological studies in rodent and non-rodent species including 28-day Good Laboratory Practice (GLP) studies in rat and monkeys. All changes are resolved or resolving after 2 weeks of dosing cessation, except for the testicular changes in rats[1]. | | References | [1]. Marta Sanchez-Martin, et al. Ahr inhibitors and uses thereof. WO2021142180A1. |
| | 1H-Carbazol-3-amine, N-[2-(5-fluoro-3-pyridinyl)-8-(1-methylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]-2,3,4,9-tetrahydro-, (3R)- Preparation Products And Raw materials |
|